In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for ...

Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...

Insmed has come up short in its attempt to expand its newly approved potential blockbuster Brinsupri into a new indication. | ...

J&J has hypothesized that subcutaneous absorption of the drug may potentially enhance immune-mediated anticancer activity.

The deal with the U.K.’s Nuclear Decommissioning Authority runs for 15 years with an option to renew for a “potentially ...